Downloads provided by UsageCounts
OSNA is a molecular assay for the detection of sentinel node metastasis. TTL emerged as a concept that seems to accurately predict the status of the NSN. Authors tried to confirm this motion. This is a retrospective and multicentric study that analyzed 2164 patients, 579 of whom had positive SN and completion AD. Logistic regression models were performed in order to identify a suitable cutoff to identify patients who benefit from AD. Univariate and multivariate regression analysis showed a relationship between TTL>30000 and the presence of NSN metastasis (OR 2.84, CI 1.99-4.08, p < 0.001). Logistic regression indicated that the cutoff of 30000 copies/μL better discriminates patients with NSN positivity and allows wide use of these criteria. This cutoff value may safely assist clinicians and patients to decide to proceed or not with an AD.
Breast Neoplasms / surgery, Adult, Receptor, ErbB-2, Sentinel Lymph Node Biopsy*, Breast Neoplasms, Receptor, ErbB-2 / metabolism, Breast Neoplasms / metabolism, Carcinoma, Lobular / surgery, Young Adult, Breast cancer, Carcinoma, Lobular / secondary*, OSNA, Humans, Lymph Nodes / surgery, Carcinoma, Lobular / metabolism, Carcinoma, Ductal, Breast / surgery, Aged, Retrospective Studies, Carcinoma, Ductal, Breast / metabolism, Aged, 80 and over, Lymph Nodes / pathology*, Sentinel Lymph Node Biopsy, Carcinoma, Ductal, Breast, Non-sentinel node, Breast Neoplasms / pathology*, Middle Aged, HCC CIR, Prognosis, Receptors, Estrogen / metabolism, Carcinoma, Lobular, Receptors, Progesterone / metabolism, Sentinel node, Receptors, Estrogen, Lymphatic Metastasis, Carcinoma, Ductal, Breast / secondary*, Lymph Nodes / metabolism, Female, Lymph Nodes, Prediction, Receptors, Progesterone, Follow-Up Studies
Breast Neoplasms / surgery, Adult, Receptor, ErbB-2, Sentinel Lymph Node Biopsy*, Breast Neoplasms, Receptor, ErbB-2 / metabolism, Breast Neoplasms / metabolism, Carcinoma, Lobular / surgery, Young Adult, Breast cancer, Carcinoma, Lobular / secondary*, OSNA, Humans, Lymph Nodes / surgery, Carcinoma, Lobular / metabolism, Carcinoma, Ductal, Breast / surgery, Aged, Retrospective Studies, Carcinoma, Ductal, Breast / metabolism, Aged, 80 and over, Lymph Nodes / pathology*, Sentinel Lymph Node Biopsy, Carcinoma, Ductal, Breast, Non-sentinel node, Breast Neoplasms / pathology*, Middle Aged, HCC CIR, Prognosis, Receptors, Estrogen / metabolism, Carcinoma, Lobular, Receptors, Progesterone / metabolism, Sentinel node, Receptors, Estrogen, Lymphatic Metastasis, Carcinoma, Ductal, Breast / secondary*, Lymph Nodes / metabolism, Female, Lymph Nodes, Prediction, Receptors, Progesterone, Follow-Up Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 6 | |
| downloads | 2 |

Views provided by UsageCounts
Downloads provided by UsageCounts